Featured Stories
News Image
Power Hour Surge: Cover Story, FDA Catalysts, Rare Earths, and a $7.8B Biotech Buyout
As the final hour of trading unfolds, momentum is clustering around breakthrough science, regulatory catalysts, strategic commodities, and headline M&A. Here are the stocks commanding attention into the close and potentially into afterhours.
24-7 Market News·Feb 24, 2026, 2:28 AM
News Image
Exposure Surge, Immunotherapy Expansion, and a $1.1B Healthcare Takeout
Midday trading is being shaped by a powerful mix of biotech momentum, breakthrough materials science, and strategic buyouts, as investors rotate toward companies delivering tangible catalysts.
24-7 Market News·Feb 23, 2026, 11:33 PM
News Image
Biotech & Obesity Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger
Wall Street opens to a convergence of science, scale, and strategic consolidation. From spider silk making mainstream headlines to multibillion-dollar oncology deals and accelerating immunotherapy revenues, today’s tape reflects capital flowing toward platforms with validation.
24-7 Market News·Feb 23, 2026, 8:52 PM
News Image
Kraig Biocraft Laboratories Featured on the Cover of National Geographic
Kraig Biocraft Laboratories (OTCQB: KBLB) groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine.
24-7 Market News·Feb 23, 2026, 6:42 PM
 More News